Intraarticular injection of adalimumab in localized psoriatic arthritis
β Scribed by M. Bouysset; F. Coury; T. Tavernier; M. Bonnin; J. Damiano; C. Nemoz; J. G. Tebib
- Book ID
- 106300804
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- French
- Weight
- 142 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0759-2280
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To evaluate the efficacy and safety of treatment with adalimumab, a fully human antiβtumor necrosis factor (antiβTNF) monoclonal antibody, over 48 weeks in patients with moderate to severe psoriatic arthritis (PsA). ## Methods Patients who completed the Adalimumab Effect
Since corticosteroids have an antiinflammatory effect, it is highly improbable that they would cause allergic reactions (1). In one patient, an intraarticular injection of methyl prednisolone acetate caused a generalized maculopapular rash which appeared a few hours after injection and lasted 4 days